Serum vitamin D and prostate cancer risk
Wednesday, December 30th, 2009 Posted in prostate cancer risks | No Comments »A recent study at German Cancer Research Center, Heidelberg, Germany aimed to review and summarize evidence on the association between serum 25-hydroxyvitamin D (25(OH)D) and the risk of prostate cancer (PC). From eleven original articles that were included, ten reported on ...
Antibody kills prostate cancer
Tuesday, December 29th, 2009 Posted in prostate cancer | No Comments »US scientists have discovered a super-molecule which targets and destroys prostate cancer cells, giving hope to men in the final stages of the disease. F77 is a monoclonal antibody which can be mass-produced in the laboratory by copying a single type ...
A new treatment option for patients with advanced prostate cancer
Monday, December 28th, 2009 Posted in hormone therapy | No Comments »Degarelix (Firmagon is a new GnRH blocker that has recently been approved by the EMEA and US FDA for the treatment of men with hormone-sensitive advanced prostate cancer. Gonadotrophin-releasing hormone (GnRH) receptor blockers (antagonists) are the latest addition to the hormonal ...
Blood pressure and risk of prostate cancer
Friday, December 25th, 2009 Posted in prostate cancer risks | No Comments »Some previous conclusions suggest that raised blood pressure may increase prostate cancer risk. A new research at University of Bristol, UK. investigated associations of blood pressure with prostate cancer within the CONOR collaborative cohorts of Norway. Reseachers concluded that raised blood ...
Routine evaluation does not predict prostate cancer
Thursday, December 24th, 2009 Posted in prostate cancer diagnosis | No Comments »A new study from the Mayo Clinic has emerged analyzing the link between prostate-specific antigen (PSA) levels and prostate size. The study concluded that routine annual evaluation of prostate growth cannot predict the development of prostate cancer. However, the study suggests ...
Obesity and prostate cancer risk
Wednesday, December 23rd, 2009 Posted in prostate cancer risks | No Comments »Some prior studies have suggested a relationship between obesity and adverse pathologic features on prostate biopsy and have suggested that obese patients may ber at higher risk for prostate cancer-related death after radical prostatectomy. However, other studies have been unable ...
Low dose, alternating electric current inhibits growth of prostate cancer
Wednesday, December 23rd, 2009 Posted in prostate cancer | No Comments »Among a number of minimally invasive technologies that exist for the treatment of prostate cancer, each with their associated morbidities, urologists think low dose alternating electric current (LDAEC) may inhibit prostate cancer growth. A research group at the University of Washington ...
Prevalence of early complications and risk factors following robotic-assisted laparoscopic radical prostatectomy
Tuesday, December 22nd, 2009 Posted in prostatectomy | No Comments »Few previous studies have evaluated the risk of side effects and complications following robotic-assisted laparoscopic radical prostatectomy (RARP), and all were flawed by several methodological biases. A recent study at University of Padua, Padua, Italy, aimd to evaluate the prevalence of ...
Non-invasive option for less advanced prostate cancer
Sunday, December 20th, 2009 Posted in hifu | No Comments »HIFU is a new treatment for prostate cancer option for younger men who have less advanced forms of the disease. HIFU stands for High Intensity Focused Ultrasound. It is a non-invasive treatment that uses ultrasound waves to focus in on ...
Histological prostatitis and its correlation with PSA density
Saturday, December 19th, 2009 Posted in prostate cancer | No Comments »A new study at Sao Paolo University, Brasil, aimed to determine the incidence of asymptomatic, histologically proven prostatitis in men with symptoms of benign prostate hyperplasia and to observe the correlation between asymptomatic prostatitis and prostate specific antigen (PSA) density. histological ...